EN
HI
Hester Biosciences Chart
Hester Biosciences Share Key Metrics
Volume
1150.00
Market Cap
1207.46 CR
LTQ@LTP
9@1425.00
ATP
1415.6
Var Margin
19.14 %
Circuit Range
1135.6-1703.2
Delivery %
57.12 %
Value
16.28 L
ASM/GSM
No
Market Lot
1
Summary
At 6 Apr, 2026 | 14:15, Hester Biosciences share price stands at ₹1425, showing a 5.60% 0.39 for the day. The stock’s intraday movement has stayed between ₹1400.00 and ₹1427.90, while on a 52-week basis it has fluctuated from ₹1239.30 to ₹2350.00.
In terms of trading activity, Hester Biosciences has recorded a volume of 1150 shares, with a market capitalisation of ₹8506865. The stock’s Average Traded Price (ATP) stands at ₹141560, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 9,142500. The stock operates within a circuit range of ₹1135.6-1703.2, with a Value of ₹16.28 L. The Delivery Percentage for the day is 57.12%. Additionally, Hester Biosciences currently falls under the No framework, and trades with a market lot size of 1.
Hester Biosciences Fundamentals
View MoreP/E Ratio
29.67
P/B Ratio
3.51
Div. Yield
0.49
Sector P/E
60.59
Sector P/B
3.25
Sec. Div. Yield
0.59
Hester Biosciences Resistance and Support
Pivot 1393.23
Resistance
First Resistance
1454.06
Second Resistance
1488.73
Third Resistance
1549.56
Support
First Support
1358.56
Second Support
1297.73
Third Support
1263.06
Hester Biosciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-01-30 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-09 | Audited Results & Final Dividend |
| 2025-01-30 | Quarterly Results |
Hester Biosciences News
Hester Biosciences Limited
Hester Biosciences' long-term bank facilities were downgraded to CARE BBB Stable from CARE BBB+ Stable by CareEdge Ratings. Short-term facilities also downgraded to CARE A3+ from CARE A2. This reassessment is based on FY25 audited and H1FY26 unaudited financials.
Mar 20 2026 15:03:00
Hester Biosciences Ltd - 524669 - Announcement under Regulation 30 (LODR)-Credit Rating
Hester Biosciences Limited's credit ratings were downgraded by CARE Ratings. The long-term bank facilities rating moved from 'BBB+; Stable' to 'BBB; Stable' based on FY25 and H1 FY26 financial performance. The company considers these ratings transitional, citing operational improvements post-September 2025.
Mar 20 2026 15:03:00
Read More
About Hester Biosciences
NSE : 7048
BSE : 524669
ISIN : INE782E01017
Hester Biosciences Management
| Name | Position |
|---|---|
| Dr. Bhupendra Gandhi | Chairman |
| Mr. Rajiv Gandhi | Managing Director & CEO |
Hester Biosciences Similar Stocks
Beta Drugs Ltd.
1355.20
-32.00 (2.31%)
NGL Fine-Chem Ltd.
2212.90
80.30 (3.77%)
Suraksha Diagnostic Ltd.
251.57
6.59 (2.69%)
Lincoln Pharmaceuticals Ltd.
578.20
-26.70 (4.41%)
Ind-Swift Laboratories Ltd.
140.21
1.36 (0.98%)
Venus Remedies Ltd.
921.85
25.25 (2.82%)
Bajaj Healthcare Ltd.
317.85
6.70 (2.15%)
Sakar Healthcare Ltd.
521.55
6.25 (1.21%)
Syncom Formulations (India) Ltd.
11.71
0.41 (3.63%)
Hester Biosciences FAQs
The Buying Price of Hester Biosciences share is 1425 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Hester Biosciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Hester Biosciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Hester Biosciences shares is 29.67. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Hester Biosciences shares is 3.51. Useful to assess the stock's value relative to its book value.
To assess Hester Biosciences’s valuation compare Sector P/E, P/B which are 60.59 & 3.25 with sector averages, along with growth rates and financial metrics.
The Market Cap of Hester Biosciences is 1207.46 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Hester Biosciences share price is 2350.00 & 1239.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Hester Biosciences belongs to the Healthcare sector.
